Aphasia Leading to the Diagnosis of Myotonic Dystrophy Type 1: A Case Report
Open Access
- 29 July 2025
- journal article
- case report
- Published by Springer Nature in Cureus
- Vol. 17 (7) , e89002
Abstract
Myotonic dystrophy type 1 (DM1) is a multisystem autosomal dominant disorder primarily characterized by myotonia and distal muscle weakness. Central nervous system (CNS) involvement, including cognitive, executive, and emotional dysfunctions, is increasingly being recognized; however, language impairment as an initial presentation is rare. A 50-year-old right-handed woman with a six-month history of progressive word-finding difficulty, vague speech, and social withdrawal was referred for evaluation. Neurological examination revealed distal muscle atrophy (grip strength: 5 kg right, 8 kg left) without overt dysarthria or dysphagia, and intact reflexes and coordination. Neuropsychological testing revealed fluent spontaneous speech with anomia, semantic paraphasia, impaired comprehension of longer sentences, and surface dyslexia/agraphia (Mini-Mental State Examination-Japanese: 22/30, Frontal Assessment Battery: 8/18, Raven's Colored Progressive Matrices: 28/36, Montreal Cognitive Assessment-Japanese: 21/30). Brain magnetic resonance imaging revealed left-sided frontotemporal and limbic atrophy, and 99mTc-ethyl cysteinate dimer single-photon emission computed tomography showed a corresponding left-dominant hypoperfusion. Amyloid positron emission tomography (PET) scan results were negative. Two weeks later, percussion and grip myotonia emerged. Genetic analysis revealed a cytosine-thymine-guanine repeat expansion (~1500 repeats) in the myotonic protein kinase 1 gene, confirming the diagnosis of DM1. The patient's semantic‐variant primary progressive aphasia-like profile (impaired semantic processing with preserved fluency) and frontotemporal imaging findings were consistent with rare CNS phenotypes reported in DM1. Previous studies have described frontotemporal atrophy, hypoperfusion, and cognitive/emotional changes in DM1. Negative amyloid PET excluded Alzheimer-related primary progressive aphasia. The subsequent detection of myotonia and a positive family history were key to diagnosis. We conclude that this case expands the clinical spectrum of DM1 to include progressive aphasia as an initial manifestation. Clinicians should maintain a high suspicion of neuromuscular disorders and actively pursue targeted genetic testing when atypical aphasia symptoms are accompanied by distal muscle atrophy.Keywords
This publication has 18 references indexed in Scilit:
- Myotonic dystrophy type 2 is rare in the Japanese populationJournal of Human Genetics, 2012
- Classification of primary progressive aphasia and its variantsNeurology, 2011
- Brief screening tool for mild cognitive impairment in older Japanese: Validation of the Japanese version of the Montreal Cognitive AssessmentGeriatrics & Gerontology International, 2010
- Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2Journal of Neurology, 2010
- Cognitive impairment in myotonic dystrophy type 1 (DM1)Journal of Neurology, 2008
- Semantic dementia: a unique clinicopathological syndromeThe Lancet Neurology, 2007
- Cerebral involvement in myotonic dystrophiesMuscle & Nerve, 2007
- Cognitive impairment in adult myotonic dystrophies: a longitudinal studyNeurological Sciences, 2007
- The FABNeurology, 2000
- Magnetic Resonance Imaging and Clinical Correlates of Intellectual Impairment in Myotonic DystrophyArchives of Neurology, 1989